Alimentary Health Announces Agreement with Mead Johnson Nutritionals
Agreement to Focus on Development of New Pediatric Nutritional Products
Cork, Ireland, April 28 2005: Alimentary Health announced today that it has entered into an exclusive research development and cross-licensing agreement with Mead Johnson Nutritionals covering nutritional applications of novel ingredient technologies for infants and children. Under the terms of the agreement, Alimentary Health and mead Johnson will each contribute their intellectual property and patented technologies to research projects and jointly fund development programs.
Barry Kiely, chief executive officer, Alimentary Health, said "we are pleased to complete this agreement with Mead Johnson. This agreement is important because it provides a commercial alliance for our technologies with a partner dedicated to providing clinically proven technology to infants and children. An alliance of this nature demonstrates the commercial viability of our mission “to improve the quality of life of patients and consumers through the development of scientifically supported technologies and products."
Alimentary Health is a development stage specialty biotechnology company linked to the
Alimentary Pharmabiotic Centre (www.apc.ucc.ie) based at University College Cork, Cork, Ireland. Alimentary Health is focused on discovery, development and commercialization of proprietary treatments for gastrointestinal disorders and other inflammatory conditions.
This press release contains forward-looking statements that are based on the companies' current beliefs and expectations, and are subject to risks and uncertainties. The companies assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact
Alimentary Health Ltd.
Dr. Barry Kiely
353(0) 21 4774715
bkiely@ahealth.ie
|
Home